• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals

Progenics Pharmaceuticals Inc PGNX

Last Price$4.89Day Change (%)-3.74%
Open Price$5.11Day Change ($)-0.19
Day Range4.80–5.2652-Week Range3.10–7.45

As of Mon 09/22/2014 03:45 PM EST | USD

  1. Investor or Speculator?

    Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...

  2. It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

    Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more effective. If successful, the firm could file for its approval in late 2009. Our fair value estimate remains unchanged, as we'd already ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.